Literature DB >> 19608996

Migraine and biomarkers of endothelial activation in young women.

Gretchen E Tietjen1, Nabeel A Herial, Leah White, Christine Utley, Janet M Kosmyna, Sadik A Khuder.   

Abstract

BACKGROUND AND
PURPOSE: There is mounting evidence of endothelial activation and dysfunction in migraine. Our objectives were to determine in a population of premenopausal women whether endothelial activation markers are associated with migraine.
METHODS: Women (18 to 50 years) with and without migraine and free from cardiovascular disease were evaluated with tests of coagulation (von Willebrand factor activity, prothrombin fragment), fibrinolysis (tissue-type plasminogen activator antigen), inflammation (high-sensitivity C-reactive protein), and oxidative stress (homocysteine, total nitrate/nitrite concentrations, thiobarbituric acid-reactive substances).
RESULTS: Sixty-one participants had migraine with aura (MA), 64 had migraine without aura (MO), and 50 were controls. Compared with controls, women with migraine had higher adjusted odds ratios for elevated von Willebrand factor activity of 6.51 (95% CI, 1.94 to 21.83) in those with MA and of 4.59 (95% CI, 1.37 to 15.38) in those with MO, elevated high-sensitivity C-reactive protein of 7.99 (95% CI, 2.32 to 27.61) in those with MA and of 2.63 (95% CI, 0.73 to 9.45) in those with MO, and for lower nitrate/nitrite levels of 6.60 (95% CI, 2.06 to 21.16) in those with MA and of 3.03 (95% CI, 0.90 to 10.15) in those with MO. Within the migraine group, von Willebrand factor activity was correlated with tissue-type plasminogen activator antigen (P=0.035) and nitrate/nitrite (P=0.024). There was a trend with high-sensitivity C-reactive protein (P=0.09).
CONCLUSIONS: In premenopausal women with migraine, particularly in those with MA, there is evidence of increased endothelial activation, a component of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608996     DOI: 10.1161/STROKEAHA.109.547901

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

1.  Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache.

Authors:  Aaron J Schain; Agustin Melo-Carrillo; Andrew M Strassman; Rami Burstein
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

2.  Migraine and risk of incident diabetes in women: a prospective study.

Authors:  Rebecca C Burch; Pamela M Rist; Anke C Winter; Julie E Buring; Aruna D Pradhan; Elizabeth W Loder; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-07-17       Impact factor: 6.292

3.  The Relationship Between Migraine or Severe Headache and Chronic Health Conditions: A Cross-Sectional Study from the National Health Interview Survey 2013-2015.

Authors:  Mia T Minen; Judith Weissman; Gretchen E Tietjen
Journal:  Pain Med       Date:  2019-11-01       Impact factor: 3.750

4.  Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study.

Authors:  Pamela M Rist; Christophe Tzourio; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-09-16       Impact factor: 6.292

Review 5.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

6.  Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study.

Authors:  Aynur Yilmaz Avci; Mehmet Husamettin Akkucuk; Ebru Torun; Serap Arikan; Ufuk Can; Mustafa Agah Tekindal
Journal:  Neurol Sci       Date:  2019-01-15       Impact factor: 3.307

Review 7.  Childhood Maltreatment in the Migraine Patient.

Authors:  Gretchen E Tietjen; Dawn C Buse; Stuart A Collins
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

8.  Structural brain changes in migraine.

Authors:  Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Lenore J Launer; Junya Konishi; Juliette M E Moonen; Jacobus T N Bakkers; Paul A M Hofman; Baldur van Lew; Huub A M Middelkoop; Mark A van Buchem; Michel D Ferrari; Mark C Kruit
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

9.  Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat.

Authors:  L F Ferrari; J D Levine; P G Green
Journal:  Neuroscience       Date:  2016-01-11       Impact factor: 3.590

10.  Migraine and vascular disease biomarkers: A population-based case-control study.

Authors:  Gretchen E Tietjen; Jagdish Khubchandani; Nabeel Herial; Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Mark A van Buchem; Lenore J Launer; Michel D Ferrari; Mark C Kruit
Journal:  Cephalalgia       Date:  2017-03-15       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.